CVTB: Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

Jcovden (COVID-19 vaccine (Ad26.COV2-S [recombinant])) - J&J

Comirnaty (tozinameran) - Pfizer, BioNTech

Vaxzevria (ChAdOx1-S recombinant) - University of Oxford, Emergent Biosolutions, Jenner Institute, Barinthus Bio, AstraZeneca

http://clinicaltrials.gov/ct2/show/NCT05571735

Apr 14, 2026